Biotechnology Market size to exceed USD 775 billion by 2024 - PowerPoint PPT Presentation

About This Presentation

Biotechnology Market size to exceed USD 775 billion by 2024


Biotechnology Market Size By Technology, By Application, Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2024 – PowerPoint PPT presentation

Number of Views:59


Transcript and Presenter's Notes

Title: Biotechnology Market size to exceed USD 775 billion by 2024

Biotechnology Market size to exceed USD 775
billion by 2024 Global Market Insights Inc.
Fuel Cell Market size worth 25.5bn by 2024
Key Insights from Biotechnology Market
  • Global biotechnology market size will reach USD
    775.20 billion by 2024, increasing from USD
    330.36 billion in 2015.
  • Tissue engineering and regeneration market share
    grabbed revenue of over 30 owing to increased
    prevalence rates of diabetes, Parkinsons and
  • Biopharmacy and Bioservices formed the largest
    application segment together contributing to over
    87 of industry revenue. The largest share can be
    attributed to the growing prevalence of chronic
    diseases globally, growing demand for
    personalized medicines, and increased government

  • Ethical issues pertaining to clinical trials and
    risks associated with GM organisms and crops will
    be a cause of concern. Genetically modified
    organismss uncontrolled nature can create a
    havoc to the human society and lack of proper
    regulations in most countries will further
    aggravate this problem.
  • With largest geriatric population base, China and
    India will be the major revenue pockets of the
    APAC region, while Brazil and Mexico are the
    revenue pullers for LATAM.

U.S. Biotechnology Market Size, by Application,
2012- 2024 (USD Million)


Browse Full Market Research Report On
Biotechnology Market _at_ http//
Request for a Sample of this Research Report
_at_ https//
/784 https//
360 Analysis
  • Product Analysis
  • Based on technology, the industry is segmented
    into tissue engineering and regeneration,
    fermentation, PCR, nanobiotechnology,
    chromatography, DNA sequencing and cell based
    assay. In 2015, the tissue engineering and
    regeneration segment accounted for highest
    revenue and was valued at over USD 104.5 billion.
    However, the nanobiotechnology, fermentation and
    cell based assay segments will experience
    lucrative growth owing to rising RD initiatives
    by various biotechnological and pharmaceutical
  • Regional Analysis
  • North America dominated the revenue share in 2015
    with over USD 137.4 billion owing to growing RD
    initiatives by key industry players and rising
    awareness among public and private research
  • Competitive Market Share
  • Major industry players are Abbott, Amgen,
    AstaZeneca, Biogen, Celgene, Genzyme, Johnson
    Johnson, Pfizer, GlaxoSmithKline, Genentech, F.
    Hoffman La Roche, Novartis, Lonza and Sanofi.

Stay In Touch Website Soci
al Media
Write a Comment
User Comments (0)